441
Participants
Start Date
June 30, 2008
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
Alogliptin
Alogliptin 25 mg, tablets, orally, once daily and glipizide placebo matching tablets, orally, once daily for up to 52 weeks.
Glipizide
Alogliptin placebo-matching tablets, orally, once daily and glipizide 5 mg to 10 mg, tablets, orally, once daily up to 52 weeks.
Alexander City
Foothill Ranch
Huntington Park
Long Beach
Los Angeles
Redlands
Prospect
Bradenton
Fort Myers
Miami
Ormond Beach
Winter Park
Roswell
Aurora
La Porte
South Bend
Salisbury
Clarkston
Omaha
Hamilton
Albuquerque
Beachwood
Westlake
Zanesville
Bensalem
Aiken
Greenville
Greer
Taylors
Corpus Christi
Dallas
Pasadena
San Antonio
Tomball
Ogden
Salt Lake City
Budapest
Miskoic
Nyíregyháza
Karnāl
Bangalore
Belagavi
Mumbai
Ashkelon
Haifa
Holon
Nahariya
Rishon LeZiyyon
Safed
Aguascalientes
Saltillo
Durango
Pachuca
Morelia
Monterrey
Guadalajara
Mexico City
Nezahualcóyotl
Arequipa
Lima
Piura
Gdansk
Krakow
Warsaw
Baia Mare
Brasov
Bucharest
Galati
Satu Mare
Arkhangelsk
Irkutsk
Smolensk
Cape Town
Centurion
Durban
Johannesburg
Port Elizabeth
Pretoria
Donetsk
Kharkiv
Lead Sponsor
Takeda
INDUSTRY